Addus HomeCare (ADUS) Q1 2026 earnings review

Growth Normalizes as Gentiva Laps, Cash Machine Roars

Addus is transitioning from acquisition-fueled hypergrowth back to its organic baseline. Revenue grew 7.7% YoY in Q1, a stark deceleration from the 25%+ clips seen in late 2025. This is not a crisis—it is the mathematical reality of fully lapping the massive December 2024 Gentiva acquisition. The underlying engine remains solid: Personal Care organic growth clocked a stable 6.5%, heavily supported by rate hikes in Texas and Illinois. While Home Health remains a bleeding laggard, Addus generated a massive $52.4M in operating cash flow, flipping the balance sheet to net cash positive. Management is immediately deploying this war chest to re-ignite M&A, announcing an entry into Indiana via the HomeCourt acquisition.

🐂 Bull Case

State Rate Tailwinds Lock In Margins

The 9.9% Texas rate increase (effective Sept 2025) and 3.9% Illinois increase (Jan 2026) are successfully buffering wage inflation and driving the 6.5% organic growth in Personal Care.

Fortress Balance Sheet Ready for M&A

Operating cash flow nearly tripled YoY to $52.4M. With $103M in cash, $94M in debt, and $547M in revolver availability, Addus has ample dry powder to consolidate a fragmented market without issuing equity.

🐻 Bear Case

Hospice Momentum Fading

Hospice organic revenue growth abruptly slowed to 7.7% from 16-19% in the second half of 2025, suggesting the post-COVID operational rebound is losing steam.

Home Health is a Dead Weight

Despite management's claim of 'complementary capabilities,' Home Health revenue shrank 6.6% organically YoY. Total volumes dropped 6.2%, making it a persistent drag on consolidated metrics.

⚖️ Verdict: 🟢

Bullish. The optical top-line deceleration was widely expected as the Gentiva deal lapped. What matters is the 6.5% core organic growth, incredible cash conversion, and immediate deployment of capital into new states (Indiana). The base business is generating cash faster than they can currently spend it.

Key Themes

DRIVERNEW🟢

Geographic Expansion Re-ignites M&A Engine

After focusing on debt paydown and Gentiva integration in 2025, M&A activity is Reversing from idle to active. Addus entered a brand new state (Indiana) by acquiring HomeCourt Home Care ($9.7M annualized revenue, 240 clients) and inked a deal for a second Indiana operator. This signals a return to the strategic playbook of building regional density via tuck-ins.

DRIVER🟢

State Rate Hikes Flow to the Bottom Line

The Personal Care segment's Stable 6.5% organic growth is heavily insulated by state Medicaid decisions. Addus is actively realizing the benefits of a 9.9% rate increase in Texas and a 3.9% increase in Illinois (effective Jan 1, 2026). This state-level support confirms management's thesis that lawmakers view home care as a critical cost-saving alternative to institutional facilities.

CONCERN🔴

Home Health Segment Remains a Bleeding Laggard

A massive contradiction exists between PR text and actual data. Management claims Home Health provides 'important complementary capabilities,' yet the segment is in a Stable but negative decline. Q1 organic revenue fell 6.6%, total volume dropped 6.2%, and visits plunged 14.5% YoY (80,892 vs 94,593). This segment is shrinking and diluting the company's otherwise stellar growth profile.

CONCERNNEW

Hospice Growth Decelerates Sharply

Hospice organic growth is Decelerating rapidly. After surging 19% in 25Q3 and 16% in 25Q4, Q1 2026 growth dropped to just 7.7%. Average daily census growth also slowed to 8.1% (down from 11.9% in Q4). While management calls the performance 'consistent,' the trajectory indicates the operational turnaround benefits achieved in 2025 have fully materialized and segment growth is returning to earth.

THEME🟢

Caregiver App Tech Rollout Buoys Volume

Addus continues to leverage its Caregiver Mobile App to maximize capacity. Personal Care billable hours rose to 10.7 million (from 10.2 million a year ago), driving 167,699 hours per business day. By providing scheduling visibility directly to caregivers, this technology allows Addus to increase the percentage of authorized hours served without necessarily acquiring new patients.

CONCERNNEW🔴

Macro: Weather Interruptions Hit January

Management flagged 'brief winter weather interruptions in January' as a minor headwind. While they claim hiring trends remained stable, home-based care businesses are highly sensitive to weather events which disrupt caregiver travel, causing unrecoverable lost billable hours.

Other KPIs

Operating Cash Flow (26Q1)$52.4 million

Accelerating dramatically. Cash provided by operations jumped 176% YoY from $18.9M in 25Q1. This massive influx was used to completely clear out Accounts Payable (down to $14.0M from $28.0M YoY) while simultaneously paying down long-term debt to $91.2M.

Personal Care Revenue Per Billable Hour$26.16

Accelerating. Up 3.3% YoY from $25.32. This metric proves that rate increases from states like Texas and Illinois are translating directly into higher unit economics, protecting gross margins (31.9%) against persistent caregiver wage inflation.

Guidance

HomeCourt Home Care Annualized Revenue$9.7 million

Accelerating inorganic revenue. Closed on May 1, 2026, this acquisition will add approximately $2.4 million in net new revenue per quarter starting in Q2 2026. Management expects this to be 'immediately accretive' to earnings, signaling healthy margins in the Indiana market.

Key Questions

Hospice Deceleration

Hospice organic growth fell from 16% in Q4 to 7.7% in Q1. Is this the new normalized run-rate for the segment, or were there specific Q1 headwinds (like weather or cap limitations) that drove the deceleration?

Home Health Strategic Review

With Home Health volumes down 6.2% YoY and visits dropping over 14%, at what point does this segment lose its 'complementary' value and become a candidate for divestiture?

Indiana Expansion Strategy

You announced the HomeCourt acquisition and a second planned deal in Indiana. What is the total target annualized revenue for the Indiana market by year-end, and how do reimbursement rates compare to your core Illinois/Texas markets?

Illinois DSO Update

Given the massive $52.4M operating cash flow generation, has the Days Sales Outstanding (DSO) issue with the Illinois Department of Aging completely resolved, or was this cash surge driven by other working capital levers?